Výsledky vyhledávání - Cloughesy, Tim
- Zobrazuji výsledky 1 - 16 z 16
-
1
ACTR-18. PHASE II TRIAL OF TEMOZOLOMIDE AND TRC 102, BASE EXCISION REPAIR INHIBITOR, IN BEVACIZUMAB NAÏVE GLIOBLASTOMA AT FIRST RECURRENCE Autor Ahluwalia, Manmeet, Drappatz, Jan, Ye, Xiaobu, Walbert, Tobias, Holdhoff, Matthias, Lesser, Glenn, Cloughesy, Tim, Peereboom, David, Burt Nabors, L, Wen, Patrick, Grossman, Stuart, Rogers, Lisa
Vydáno 2018Text -
2
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: A North American Brain Tumor Consortium (NABTC01-05) Autor Butowski, Nicholas, Chang, Susan M., Junck, Larry, DeAngelis, Lisa M., Abrey, Lauren, Fink, Karen, Cloughesy, Tim, Lamborn, Kathleen R., Salazar, Andres M., Prados, Michael D.
Vydáno 2008Text -
3
ATIM-38. PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB, DURVA) + BEVACIZUMAB (BEV) IN BEV-NAÏVE PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) Autor Reardon, David, Kaley, Thomas, Dietrich, Jorg, Clarke, Jennifer, Dunn, Gavin, Lim, Michael, Cloughesy, Tim, Gan, Hui, Park, Andrew, Schwarzenberger, Paul, Ricciardi, Toni, Macri, Mary, Ryan, Aileen, Venhaus, Ralph
Vydáno 2018Text -
4
ATIM-39. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION Autor Antonios, Joseph, Everson, Richard, Soto, Horacio, Khattab, Sara, Bethel, Jacob, Sun, Matthew, Mochizuki, Aaron, Lee, Alexander, Odesa, Sylvia, Billingslea-Yoon, Emma, Moughon, Diana, Wang, Anthony, Cloughesy, Tim, Prins, Robert, Liau, Linda
Vydáno 2018Text -
5
AT-18 SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NE... Autor Cloughesy, Tim, Wick, Wolfgang, Mason, Warren, Henriksson, Roger, Saran, Frank, Nishikawa, Ryo, Carpentier, Antoine F., Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana, Brandes, Alba A., Revil, Cedric, Abrey, Lauren, Chinot, Olivier L.
Vydáno 2014Text -
6
ET-12 PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA Autor Cloughesy, Tim, Finocchiaro, Gaetano, Belda-Iniesta, Cristobel, Recht, Lawrence, Brandes, Alba A, Pineda, Estela, Mikkelsen, Tom, Chinot, Olivier, Balana, Carmen, Macdonald, David, Westphal, Manfred, Hopkins, Kirsten, Weller, Michael, Bruey, Jean-Marie, Liu, Bo, Verret, Wendy
Vydáno 2014Text -
7
Phase II Study of Bortezomib in Combination with Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients with Newly-Diagnosed Glioblastoma Multiforme: Safety... Autor Kong, Xiao-Tang, Nguyen, Nhung T., Choi, Yoon J., Zhang, Guicheng, Nguyen, HuyTram N., Filka, Emese, Green, Stacey, Yong, William H., Liau, Linda M., Green, Richard M., Kaprealian, Tania, Pope, Whitney B., Nghiemphu, P. Leia, Cloughesy, Tim, Lassman, Andrew, Lai, Albert
Vydáno 2018Text -
8
Myeloid Biomarkers Associated with Glioblastoma Response to Anti-Vascular Endothelial Growth Factor Therapy with Aflibercept Autor de Groot, John F, Piao, Yuji, Tran, Hai, Gilbert, Mark, Wu, Hua-Kang, Liu, Jun, Bekele, B. Nebiyou, Cloughesy, Tim, Mehta, Minesh, Robins, H. Ian, Lassman, Andrew, DeAngelis, Lisa, Camphausen, Kevin, Chen, Alice, Yung, WKA, Prados, Michael, Wen, Patrick Y., Heymach, John V
Vydáno 2011Text -
9
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy Autor Munster, Pamela, Mita, Monica, Mahipal, Amit, Nemunaitis, John, Massard, Christophe, Mikkelsen, Tom, Cruz, Cristina, Paz-Ares, Luis, Hidalgo, Manuel, Rathkopf, Dana, Blumenschein Jr, George, Smith, David C, Eichhorst, Barbara, Cloughesy, Tim, Filvaroff, Ellen H, Li, Shaoyi, Raymon, Heather, de Haan, Hans, Hege, Kristen, Bendell, Johanna C
Vydáno 2019Text -
10
Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma Autor Cloughesy, Tim F, Yoshimoto, Koji, Nghiemphu, Phioanh, Brown, Kevin, Dang, Julie, Zhu, Shaojun, Hsueh, Teli, Chen, Yinan, Wang, Wei, Youngkin, David, Liau, Linda, Martin, Neil, Becker, Don, Bergsneider, Marvin, Lai, Albert, Green, Richard, Oglesby, Tom, Koleto, Michael, Trent, Jeff, Horvath, Steve, Mischel, Paul S, Mellinghoff, Ingo K, Sawyers, Charles L
Vydáno 2008Text -
11
De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients Autor Akhavan, David, Pourzia, Alexandra L., Nourian, Alex A., Williams, Kevin J., Nathanson, David, Babic, Ivan, Villa, Genaro R., Tanaka, Kazuhiro, Nael, Ali, Yang, Huijun, Dang, Julie, Vinters, Harry V., Yong, William H., Flagg, Mitchell, Tamanoi, Fuyuhiko, Sasayama, Takashi, James, C. David, Kornblum, Harley I., Cloughesy, Tim F., Cavenee, Webster K., Bensinger, Steven J., Mischel, Paul S.
Vydáno 2013Text -
12
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis Autor McGillicuddy, Lauren T., Fromm, Jody A., Hollstein, Pablo E., Kubek, Sara, Beroukhim, Rameen, De Raedt, Thomas, Johnson, Bryan W., Williams, Sybil M.G., Nghiemphu, Phioanh, Liau, Linda, Cloughesy, Tim F., Mischel, Paul S., Parret, Annabel, Seiler, Jeanette, Moldenhauer, Gerd, Scheffzek, Klaus, Stemmer-Rachamimov, Anat O., Sawyers, Charles L., Brennan, Cameron, Messiaen, Ludwine, Mellinghoff, Ingo K., Cichowski, Karen
Vydáno 2009Text -
13
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma Autor Singh, Kirit, Batich, Kristen A., Wen, Patrick Y., Tan, Aaron C., Bagley, Stephen J., Lim, Michael, Platten, Michael, Colman, Howard, Ashley, David M., Chang, Susan M., Rahman, Rifaquat, Galanis, Evanthia, Mansouri, Alireza, Puduvalli, Vinay K., Reardon, David A., Sahebjam, Solmaz, Sampson, John H., Simes, John, Berry, Donald A., Zadeh, Gelareh, Cloughesy, Tim F., Mehta, Minesh P., Piantadosi, Steven, Weller, Michael, Heimberger, Amy B., Khasraw, Mustafa
Vydáno 2022Text -
14
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma Autor Beroukhim, Rameen, Getz, Gad, Nghiemphu, Leia, Barretina, Jordi, Hsueh, Teli, Linhart, David, Vivanco, Igor, Lee, Jeffrey C., Huang, Julie H., Alexander, Sethu, Du, Jinyan, Kau, Tweeny, Thomas, Roman K., Shah, Kinjal, Soto, Horacio, Perner, Sven, Prensner, John, Debiasi, Ralph M., Demichelis, Francesca, Hatton, Charlie, Rubin, Mark A., Garraway, Levi A., Nelson, Stan F., Liau, Linda, Mischel, Paul S., Cloughesy, Tim F., Meyerson, Matthew, Golub, Todd A., Lander, Eric S., Mellinghoff, Ingo K., Sellers, William R.
Vydáno 2007Text -
15
Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain Autor Lee, Jeffrey C, Vivanco, Igor, Beroukhim, Rameen, Huang, Julie H. Y, Feng, Whei L, DeBiasi, Ralph M, Yoshimoto, Koji, King, Jennifer C, Nghiemphu, Phioanh, Yuza, Yuki, Xu, Qing, Greulich, Heidi, Thomas, Roman K, Paez, J. Guillermo, Peck, Timothy C, Linhart, David J, Glatt, Karen A, Getz, Gad, Onofrio, Robert, Ziaugra, Liuda, Levine, Ross L, Gabriel, Stacey, Kawaguchi, Tomohiro, O'Neill, Keith, Khan, Haumith, Liau, Linda M, Nelson, Stanley F, Rao, P. Nagesh, Mischel, Paul, Pieper, Russell O, Cloughesy, Tim, Leahy, Daniel J, Sellers, William R, Sawyers, Charles L, Meyerson, Matthew, Mellinghoff, Ingo K
Vydáno 2006Text -
16
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma Autor Arrieta, Víctor A., Chen, Andrew X., Kane, J. Robert, Kang, Seong Jae, Kassab, Cynthia, Dmello, Crismita, Zhao, Junfei, Burdett, Kirsten B., Upadhyayula, Pavan, Lee-Chang, Catalina, Shilati, Joseph, Jaishankar, Dinesh, Chen, Li, Gould, Andrew, Zhang, Daniel, Yuan, Jinzhou, Zhao, Wenting, Ling, Xiaoyang, Burks, Jared K., Laffleur, Brice, Amidei, Christina, Bruce, Jeffrey N., Lukas, Rimas V., Yamaguchi, Jonathan T., Cieremans, David, Rothschild, Gerson, Basu, Uttiya, McCord, Matthew, Brat, Daniel J., Zhang, Hui, Cooper, Lee A. D., Zhang, Bin, Sims, Peter, Cloughesy, Tim F., Prins, Robert, Canoll, Peter, Stupp, Roger, Heimberger, Amy B., Horbinski, Craig, Iwamoto, Fabio M., Rabadan, Raul, Sonabend, Adam M.
Vydáno 2021Text